Abstract
Hepatitis C virus (HCV) is highly prevalent in the criminal justice system and in persons who inject drugs, particularly opioids. Data on the impact of medications for opioid use disorder (MOUD) are abundant for infectious and noninfectious outcomes but are limited for justice-involved settings. This systematic review and meta-analysis focuses on the impact of MOUD on HCV incidence for persons in prisons and jails. Six studies were included in the qualitative synthesis, of which four were included for meta-analysis. A varied MOUD effect on HCV incidence was observed in part due to wide variability in prison and jail risk environments.
Author supplied keywords
Cite
CITATION STYLE
Seval, N., Wurcel, A., Gunderson, C. G., Grimshaw, A., & Springer, S. A. (2020, September 1). The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review. Infectious Disease Clinics of North America. W.B. Saunders. https://doi.org/10.1016/j.idc.2020.06.011
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.